Plasma soluble tumor necrosis factor-α receptors circulate in proportion to leptin levels during the menstrual cycle in lean but not in obese women

被引:17
作者
Fernández-Real, JM
Gutierrez, C
Vendrell, J
Casamitjana, R
Ricart, W
机构
[1] Hosp Univ Girona Dr Josep Trueta, Unitat Diabet Endocrinol & Nutr, Girona 17007, Spain
[2] Hosp Univ Tarragona Joan XXIII, Unitat Endocrinol & Nutr, Tarragona, Spain
[3] Hosp Clin Barcelona, Serv Lab Hormonal, Barcelona, Spain
关键词
D O I
10.1530/eje.0.1430235
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: In recent studies serum leptin levels were significantly higher in the luteal phase than in the follicular phase, but the mechanism of changing leptin levels are unknown. Several research lines indicate a potential role for tumor necrosis Factor (TNF-alpha) in ovulation and reproductive events. As TNF-alpha appears to regulate leptin secretion, we speculated that TNF-alpha might be involved in leptin variations during the menstrual cycle. Design and methods: Nine healthy never obese and ten overweight normally cycling women were studied, TNF-alpha action - through the plasma levels of the soluble fraction of the tumor necrosis factor receptors 1 and 2 (sTNFR1 and sTNFR2) - and leptin concentrations were measured in the follicular(F), peri-ovulatory (PO) and luteal phases (L) of :heir menstrual cycles. Results: Circulating leptin levels were significantly associated with the stage of the menstrual cycle (P<0.001), being higher in PO and L phases. However, only three of ten overweight subjects vs eight of nine lean women (Chi square P = 0.014 after Fisher's exact test) showed significantly higher leptin levels in the PO and L than in the F phase (95% confidence interval (95% CI) of the differences, 3.7 to 10.2 ng/ml, paired t-test P= 0.001), In these women (group 1), the changes in leptin levels parallelled the variations observed in plasma sTNFR1 (2.53 +/- 0.1 vs 2.11 +/- 0.05 ng/ml, P<0.0001, 95% CI, 0.21 to 0.56) and sTNFR2 levels (5.19 +/- 0.28 vs 4.55 +/- 0.25 ng/ml, P< 0.0001, 95% CI, 0.47 to 0.81). In the remaining women (group 2), leptin (95% CI, -1 to 9.2 ng/ml, P = not significant (NS)), sTNFR1 (95% CI, -0.3 to 0.14 ng/ml, P=NS) and sTNFR2 levels (95% CI, -0.95 to 0.39 ng/ml, P = NS) were essentially unaltered throughout the menstrual cycle. Group 2 women were similar in age (36.1 +/- 2.9 vs 37.3 +/- 1.4 years) and significantly overweight (body mass index 31 +/- 7.9 vs 23.9 +/- kg/m(2)) compared with group 1 women. A negative correlation was observed between leptin levels in the follicular phase and the change in plasma leptin from F to L phase in all subjects (r= - 0.67. P = 0.002). Conclusions: Circulating leptin and sTNFRs levels change significantly during the menstrual cycle of most lean women. In contrast, the levels of these molecules remain essentially unaltered during the F. PO and L phases in the majority of overweigh: women. Obesity might be associated not only with blunted diurnal excursions and dampened pulsatility but also with blunted excursions during the menstrual cycle.
引用
收藏
页码:235 / 241
页数:7
相关论文
共 38 条
[1]   STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].
ADERKA, D ;
ENGELMANN, H ;
MAOR, Y ;
BRAKEBUSCH, C ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329
[2]   Leptin is a metabolic signal to the reproductive system [J].
Barash, IA ;
Cheung, CC ;
Weigle, DS ;
Ren, HP ;
Kabigting, EB ;
Kuijper, JL ;
Clifton, DK ;
Steiner, RA .
ENDOCRINOLOGY, 1996, 137 (07) :3144-3147
[3]  
BARR SI, 1995, AM J CLIN NUTR, V61, P39
[4]   EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) ON OVULATION IN THE RAT OVARY [J].
BRANNSTROM, M ;
BONELLO, N ;
WANG, LJ ;
NORMAN, RJ .
REPRODUCTION FERTILITY AND DEVELOPMENT, 1995, 7 (01) :67-73
[5]   RAT OVARY PRODUCES CYTOKINES DURING OVULATION [J].
BRANNSTROM, M ;
NORMAN, RJ ;
SEAMARK, RF ;
ROBERTSON, SA .
BIOLOGY OF REPRODUCTION, 1994, 50 (01) :88-94
[6]  
Bray George A., 1997, Human Reproduction (Oxford), V12, P26
[7]   Serum leptin concentrations during the menstrual cycle in normal-weight women: effects of an oral triphasic estrogen-progestin medication [J].
Cella, F ;
Giordano, G ;
Cordera, R .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 142 (02) :174-178
[8]  
Chegini N, 1999, AM J REPROD IMMUNOL, V42, P297
[9]   Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin [J].
Chehab, FE ;
Lim, ME ;
Lu, RH .
NATURE GENETICS, 1996, 12 (03) :318-320
[10]   Early onset of reproductive function in normal female mice treated with leptin [J].
Chehab, FF ;
Mounzih, K ;
Lu, RH ;
Lim, ME .
SCIENCE, 1997, 275 (5296) :88-90